• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估离子电渗疗法辅助角膜交联术与标准角膜交联术治疗圆锥角膜的疗效和安全性。

Evaluating the efficacy and safety of iontophoresis-assisted corneal cross-linking compared to standard CXL in the treatment of keratoconus.

作者信息

Alqudah Noor, Alqudah Asem, Alshamarti Sarah, Shannak Zaki

机构信息

Department of Special Surgery, Division of Ophthalmology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.

Department of Ophthalmology, Alqadisiyah University, Faculty of Medicine, Diwaniyeh, Iraq.

出版信息

Indian J Ophthalmol. 2025 Jul 1;73(7):953-958. doi: 10.4103/IJO.IJO_1836_24. Epub 2025 Apr 17.

DOI:10.4103/IJO.IJO_1836_24
PMID:40243077
Abstract

PURPOSE

To compare the outcomes of standard corneal cross-linking (S-CXL) and iontophoresis-assisted CXL (I-CXL) in Jordanian keratoconus patients over a 12-month follow-up period.

DESIGN

This retrospective, observational cohort study included 107 keratoconus patients who underwent either S-CXL (n = 53) or I-CXL (n = 54) between January 2015 and December 2019.

METHODS

Data collected included demographic information, clinical history, and ophthalmic examinations. The primary outcome was the change in best-corrected visual acuity (BCVA) from baseline to 12 months post-procedure. Secondary outcomes included changes in spherical equivalent, cylindrical values, corneal curvature (K 1 , K 2 , K mean , K max ), and thinnest corneal location. Postoperative complications, such as corneal haze, keratitis, and the need for penetrating keratoplasty, were also assessed. Statistical analysis was performed using R statistical software.

RESULTS

The mean age of patients was 25.0 years, with a male predominance (60%). Decreased vision was the most common symptom (63%). BCVA improvement was similar in both groups at all intervals. At 12 months, the mean BCVA change was 0.05 in the S-CXL group and 0.04 in the I-CXL group. No significant differences were observed in spherical equivalent values. Corneal curvature values (K 1 , K 2 , K mean , K max ) were significantly higher in the I-CXL group. Postoperative complications were minimal, with 40% of S-CXL patients and 93% of I-CXL patients experiencing no complications. Mild haze was more common in the S-CXL group (54%).

CONCLUSIONS

S-CXL demonstrated superiority in improving corneal curvature at 6 and 12 months. Postoperative complications were minimal, with higher incidence of mild haze in the S-CXL group. Further studies with larger sample sizes and longer follow-up periods are needed to confirm these results.

摘要

目的

比较标准角膜交联术(S-CXL)和离子导入辅助角膜交联术(I-CXL)在约旦圆锥角膜患者12个月随访期内的治疗效果。

设计

这项回顾性观察队列研究纳入了2015年1月至2019年12月期间接受S-CXL(n = 53)或I-CXL(n = 54)治疗的107例圆锥角膜患者。

方法

收集的数据包括人口统计学信息、临床病史和眼科检查。主要结局是从基线到术后12个月最佳矫正视力(BCVA)的变化。次要结局包括球镜等效度、柱镜值、角膜曲率(K1、K2、K均值、K最大值)和最薄角膜位置的变化。还评估了术后并发症,如角膜混浊、角膜炎以及穿透性角膜移植术的需求。使用R统计软件进行统计分析。

结果

患者的平均年龄为25.0岁,男性占主导(60%)。视力下降是最常见的症状(63%)。两组在所有时间间隔的BCVA改善情况相似。在12个月时,S-CXL组的平均BCVA变化为0.05,I-CXL组为0.04。球镜等效度值未观察到显著差异。I-CXL组的角膜曲率值(K1、K2、K均值、K最大值)显著更高。术后并发症极少,40%的S-CXL患者和93%的I-CXL患者未出现并发症。轻度混浊在S-CXL组更常见(54%)。

结论

S-CXL在改善6个月和12个月时的角膜曲率方面表现出优势。术后并发症极少,S-CXL组轻度混浊的发生率较高。需要更大样本量和更长随访期的进一步研究来证实这些结果。

相似文献

1
Evaluating the efficacy and safety of iontophoresis-assisted corneal cross-linking compared to standard CXL in the treatment of keratoconus.评估离子电渗疗法辅助角膜交联术与标准角膜交联术治疗圆锥角膜的疗效和安全性。
Indian J Ophthalmol. 2025 Jul 1;73(7):953-958. doi: 10.4103/IJO.IJO_1836_24. Epub 2025 Apr 17.
2
Safety and efficacy of simultaneous photorefractive keratectomy and corneal cross-linking in managing suspected keratoconus.准分子激光原位角膜磨镶术与角膜交联术联合治疗疑似圆锥角膜的安全性和有效性
Indian J Ophthalmol. 2025 Jul 1;73(7):959-965. doi: 10.4103/IJO.IJO_1941_24. Epub 2025 Apr 17.
3
Standard and accelerated crosslinking protocols in keratoconus - differences and evolution at one year.圆锥角膜的标准和加速交联方案——一年时的差异与进展
Rom J Ophthalmol. 2025 Apr-Jun;69(2):175-183. doi: 10.22336/rjo.2025.29.
4
Evaluation of refractive, tomographic and biomechanical changes after customized accelerated corneal collagen cross-linking in keratoconus patients: a retrospective observational study.圆锥角膜患者定制加速角膜胶原交联术后屈光、断层扫描及生物力学变化的评估:一项回顾性观察研究。
BMC Ophthalmol. 2025 Jul 1;25(1):378. doi: 10.1186/s12886-025-04195-5.
5
Pulsed corneal crosslinking in the treatment of Keratoconus: a systematic review and meta-analysis.脉冲角膜交联术治疗圆锥角膜:一项系统评价与荟萃分析
Graefes Arch Clin Exp Ophthalmol. 2025 Mar;263(3):589-601. doi: 10.1007/s00417-024-06622-7. Epub 2024 Aug 31.
6
Clinical outcomes of Bowman-Stromal inlay and corneal collagen crosslinking in contralateral eyes in patients with progressive keratoconus.进行性圆锥角膜患者对侧眼Bowman层-基质层植入术与角膜胶原交联术的临床结果
Indian J Ophthalmol. 2025 Jul 1;73(7):966-973. doi: 10.4103/IJO.IJO_1013_24. Epub 2025 Jun 30.
7
Corneal Densitometry and Higher Order Aberrations After Corneal Transplantation and Corneal Cross-Linking for Keratoconus: 3-Year Results.圆锥角膜角膜移植和角膜交联术后的角膜密度测量及高阶像差:3年结果
J Refract Surg. 2025 Jul;41(7):e715-e723. doi: 10.3928/1081597X-20250515-08. Epub 2025 Jul 1.
8
Corneal collagen cross-linking for treating keratoconus.角膜交联术治疗圆锥角膜
Cochrane Database Syst Rev. 2015 Mar 24;2015(3):CD010621. doi: 10.1002/14651858.CD010621.pub2.
9
Keratometry Changes Between Year One to Seven After Corneal Cross-Linking in Patients With Keratoconus.角膜交联术后一年至七年角膜曲率变化:圆锥角膜患者的研究。
Cornea. 2024 Nov 1;43(11):1397-1402. doi: 10.1097/ICO.0000000000003478. Epub 2024 Jan 30.
10
Comparative Analysis of Combined Topography-Guided Photorefractive Keratectomy and Corneal Crosslinking in Progressive Versus Stable Keratoconus.进行性与稳定性圆锥角膜中联合地形引导的准分子激光原位角膜磨镶术和角膜交联术的对比分析
Cornea. 2024 Jul 31;44(8):983-991. doi: 10.1097/ICO.0000000000003653.

本文引用的文献

1
Management of keratoconus: an updated review.圆锥角膜的管理:最新综述。
Front Med (Lausanne). 2023 Jun 20;10:1212314. doi: 10.3389/fmed.2023.1212314. eCollection 2023.
2
Keratoconus epidemiology: A review.圆锥角膜流行病学:综述
Saudi J Ophthalmol. 2022 Jul 11;36(1):3-6. doi: 10.4103/sjopt.sjopt_204_21. eCollection 2022 Jan-Mar.
3
Keratoconus: An updated review.圆锥角膜:更新综述。
Cont Lens Anterior Eye. 2022 Jun;45(3):101559. doi: 10.1016/j.clae.2021.101559. Epub 2022 Jan 4.
4
The Prevalence and Risk Factors for Keratoconus: A Systematic Review and Meta-Analysis.圆锥角膜的患病率及危险因素:系统评价和荟萃分析。
Cornea. 2020 Feb;39(2):263-270. doi: 10.1097/ICO.0000000000002150.
5
Late onset corneal haze after corneal cross-linking for progressive keratoconus.圆锥角膜交联术后迟发性角膜混浊
Am J Ophthalmol Case Rep. 2019 Feb 26;14:64-66. doi: 10.1016/j.ajoc.2019.02.008. eCollection 2019 Jun.
6
Prevalence and Incidence of Keratoconus in South Korea: A Nationwide Population-based Study.韩国圆锥角膜的患病率和发病率:一项全国性基于人群的研究。
Am J Ophthalmol. 2018 Aug;192:56-64. doi: 10.1016/j.ajo.2018.04.027. Epub 2018 May 8.
7
Outcomes of iontophoretic corneal collagen crosslinking in keratoconic eyes with very thin corneas.角膜非常薄的圆锥角膜患者行离子导入角膜胶原交联术的效果。
Medicine (Baltimore). 2017 Nov;96(47):e8758. doi: 10.1097/MD.0000000000008758.
8
Iontophoretic collagen cross-linking versus epithelium-off collagen cross-linking for early stage of progressive keratoconus - 3 years follow-up study.离子导入胶原交联与上皮去除胶原交联治疗早期进行性圆锥角膜的3年随访研究
Acta Ophthalmol. 2017 Nov;95(7):e649-e655. doi: 10.1111/aos.13538.
9
Recent advances in corneal collagen cross-linking.角膜胶原交联的最新进展。
Indian J Ophthalmol. 2017 Sep;65(9):787-796. doi: 10.4103/ijo.IJO_648_17.
10
Iontophoresis-assisted corneal crosslinking using 0.1% riboflavin for progressive keratoconus.使用0.1%核黄素进行离子电渗疗法辅助角膜交联治疗进行性圆锥角膜。
Int J Ophthalmol. 2017 May 18;10(5):717-722. doi: 10.18240/ijo.2017.05.09. eCollection 2017.